Search Results1-20 of  31

  • 1 / 2
  • KANKI Masayuki ID: 9000258713113

    Drug Safety Research Labs., Astellas Pharma Inc. (2013 from CiNii)

    Articles in CiNii:1

    • Identification of novel biomarkers for drug-induced renal papillary necrosis in rats by toxicoproteomics (2013)
  • KANKI Masayuki ID: 9000258713303

    Drug Safety Research Laboratories, Astellas Pharma Inc. (2013 from CiNii)

    Articles in CiNii:1

    • Relationship between regional variation of renal miRNA expression and nephrotoxicity (2013)
  • KANKI Masayuki ID: 9000258714178

    Drug Safety Research Labs, Astellas Pharma Inc. (2013 from CiNii)

    Articles in CiNii:1

    • Relationship between DNA methylation and gene expression in liver carcinogenesis (2013)
  • KANKI Masayuki ID: 9000258714196

    Drug Safety Research Laboratories, Astellas Pharma Inc. (2013 from CiNii)

    Articles in CiNii:1

    • Characterization of urinary microRNAs that could detect cisplatin-induced nephrotoxicity in rat (2013)
  • KANKI Masayuki ID: 9000283730333

    Drug Safety Research Labs., Astellas Pharma Inc. (2012 from CiNii)

    Articles in CiNii:1

    • Toxicoproteomic and toxicogenomic approaches: Identification and verification of novel biomarkers for renal papillary necrosis in rats (2012)
  • KANKI Masayuki ID: 9000283730862

    Drug Safety Research Laboratories, Astellas Pharma Inc. (2012 from CiNii)

    Articles in CiNii:1

    • MicroRNA expression analysis in cisplatin-treated rat urine (2012)
  • KANKI Masayuki ID: 9000283730872

    Drug Safety Research Laboratories, Astellas Pharma Inc. (2012 from CiNii)

    Articles in CiNii:1

    • Molecular toxicological evaluations of hepatocarcinogenesis in rat 2-stage liver carcinogenesis model -4. hepatic glycan profile analysis by using lectin array (2012)
  • KANKI Masayuki ID: 9000283730883

    Drug Safety Research Laboratories, Astellas Pharma Inc. (2012 from CiNii)

    Articles in CiNii:1

    • Molecular toxicological evaluations of hepatocarcinogenesis in rat 2-stage liver carcinogenesis model -1. application of toxicogenomics for sensitive detection of initiation activity of hepatocarcinogens (2012)
  • KANKI Masayuki ID: 9000283730888

    Drug Safety Research Labs, Astellas Phrama Inc. (2012 from CiNii)

    Articles in CiNii:1

    • Molecular toxicological evaluations of hepatocarcinogenesis in rat 2-stage liver carcinogenesis model -2. comprehensive microRNA analysis and exploring biomarkers in the liver and plasma (2012)
  • KANKI Masayuki ID: 9000283730907

    Drug Safety Research Labs, Astellas Pharma Inc. (2012 from CiNii)

    Articles in CiNii:1

    • Molecular toxicological evaluations of hepatocarcinogenesis in rat 2-stage liver carcinogenesis model -3. Comprehensive DNA methylation analysis of liver using next generation sequencer (2012)
  • KANKI Masayuki ID: 9000283732788

    Drug Safety Research Labs., Astellas Pharma Inc., Japan (2012 from CiNii)

    Articles in CiNii:1

    • Identification and verification of novel biomarkers for drug-induced renal papillary necrosis in rats using toxicoproteomic and toxicogenomic approaches (2012)
  • KANKI Masayuki ID: 9000345268078

    Drug Safety Research Labs, Astellas Pharma Inc. (2016 from CiNii)

    Articles in CiNii:1

    • Urinary microRNA biomarkers in drug-induced nephrotoxicity (2016)
  • KANKI Masayuki ID: 9000347140840

    Drug Safety Research Laboratories, Astellas Pharma Inc. (2014 from CiNii)

    Articles in CiNii:1

    • Evaluation of usability of exosomal miR-122 in rat models of drug-induced liver injury (2014)
  • KANKI Masayuki ID: 9000347141105

    Drug Safety Research Laboratories, Astellas Pharma Inc. (2014 from CiNii)

    Articles in CiNii:1

    • MicroRNA biomarkers in urine for detection of drug-induced nephrotoxicity (2014)
  • KANKI Masayuki ID: 9000391993311

    Drug Safety Research Laboratories, Drug Discovery Research Division, Astellas Pharma Inc. (2009 from CiNii)

    Articles in CiNii:1

    • Prediction model construction and marker genes extraction for cholestasis using toxicogenoimcs approach in rats (2009)
  • KANKI Masayuki ID: 9000391995037

    Drug Safety Research Laboratories, Astellas Pharma Inc. (2010 from CiNii)

    Articles in CiNii:1

    • Novel biomarkers of glutathione depletion associated hepatotoxicity by using cross-omics technology (2010)
  • KANKI Masayuki ID: 9000391997954

    Drug Safety Research Laboratories, Astellas Pharma Inc. (2010 from CiNii)

    Articles in CiNii:1

    • Computational approach for assessment of glutathione depletion based on gene expression data (2010)
  • KANKI Masayuki ID: 9000391998032

    Drug Safety Research Labs., Astellas Pharma Inc. (2010 from CiNii)

    Articles in CiNii:1

    • Construction of a toxicogenomic prediction model for the hepatocyte necrosis in rats (2010)
  • KANKI Masayuki ID: 9000391998135

    Drug Safety Research Laboratories, Astellas Pharma Inc. (2010 from CiNii)

    Articles in CiNii:1

    • Toxicogenomic approach for identifying marker genes of liver toxicity in rat whole blood (2010)
  • KANKI Masayuki ID: 9000391998629

    Molecular Toxiclogy, Drug safety research Labs., Astellas Pharma Inc. (2010 from CiNii)

    Articles in CiNii:1

    • Gene expression profile in rat ovarian follicle during ovulation (2010)
  • 1 / 2
Page Top